Description

In this episode of Fat Science, Dr. Emily Cooper, Andrea Taylor and Mark Wright explore the world of compounded drugs. These are medications prepared by pharmacists to meet specific needs of patients when commercially-available products are not an option. Changes in dose, accommodating patients with allergies or sensitivities and drug shortages are some of the reasons the FDA allows compounded drugs to be made and sold.

Key Takeaways:

• Compounded drugs are manufactured by pharmacies to offer alternatives to brand medications but lack FDA approval for safety and efficacy.
• Loopholes in drug shortage laws have allowed a surge in compounded GLP1s, though these shortages are now being resolved.
• Concerns arise over the quality, dosing, and potential immune reactions that compounded drugs might provoke, especially when not FDA-tested.
• Choosing FDA-approved drugs ensures strict regulation, accountability and proper testing to safeguard health.
• Consumers face aggressive marketing tactics aiming to sell compounded drugs at lower prices without guarantees of safety or effectiveness.

Resources:

• Connect with Dr. Emily Cooper on LinkedIn.
• Connect with Mark Wright on LinkedIn.
• Connect with Andrea Taylor on Instagram.

Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. We are committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.

If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org.

Fat Science is supported by the non-profit Diabesity Institute which is on a mission to increase access to effective, science-based medical care for those suffering from or at risk for diabesity. https://diabesityresearchfoundation.org/